Abstract
To elucidate the biological significance of selectin for idiopathic pulmonary fibrosis, we titrated the serum soluble E-selectin. From 31 cases of idiopathic pulmonary fibrosis patients without signs or symptoms of infection, the serum was obtained and the concentration was titrated by enzyme-linked immunosorbent assay. The serum soluble E-selectin titer was significantly higher than that of healthy controls. However, significant elevation was not observed in the sera from the patients with other pulmonary diseases, such as pulmonary emphysema, sarcoidosis, or bronchiectasis. In the patients with idiopathic pulmonary fibrosis, the number of white blood cells, C-reactive protein or lactate dehydrogenase activity did not show a significant relationship with the soluble E-selectin titer. About 16 out of the 31 idiopathic fibrosis patients, the serum surfactant apoprotein-A titer, which is a parameter of the disease activity of idiopathic pulmonary fibrosis, was also tested. The surfactant apoprotein-A titer was loosely correlated with the soluble E-selectin titer. These observations suggest that E-selectin may be relevant to the pathogenesis of idiopathic pulmonary fibrosis, and it may be a novel clinical parameter for idiopathic pulmonary fibrosis.
Similar content being viewed by others
REFERENCES
Schwartz, D. A., R. A. Helmers, C. S. Dayton, R. K. Merchant, and G. W. Hunninghake. 1991. Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis. J. Appl. Physiol. 71: 1688-1693.
Cherniack, R. M., T. V. Colby, A. Flint, W. M. Thurlbeck, J. Waldron, L. Ackerson, and T. E. King, Jr. 1991. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am. Rev. Respir. Dis. 144: 892-900.
Sakuma-Mochizuki, J., M. Yoshida, K. Abe, T. Arai, M. Mori, Y. Kaneda, and S. Hayashi. 2000. Changes in pulmonary histology and exfoliated bronchoalveolar cells induced by in vivo introduction of the tumor necrosis factor-alpha gene. Inflammation 24: 11-19.
Yoshida, M., J. Sakuma, S. Hayashi, K. Abe, I. Saito, S. Harada, M. Sakatani, S. Yamamoto, N. Matsumoto, Y. Kaneda, and T. Kishimoto. 1995. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc. Natl. Acad. Sci. U. S. A. 92: 9570-9574.
Obayashi, Y., I. Yamadori, J. Fujita, T. Yoshinouchi, N. Ueda, and J. Takahara. 1997. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 112: 1338-1343.
Bennett, C. F., T. P. Condon, S. Grimm, H. Chan, and M.-Y. Chiang. 1994. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152: 3530-3540.
Sriramarao, P., U. H. von Andrian, E. C. Butcher, M. A. Bourdon, and D. H. Broide. 1994. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J. Immunol. 153: 4238-4246.
Weyrich, A. S., X.-l. Ma, D. J. Lefer, K. H. Albertine, and A. M. Lefer. 1993. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91: 2620-2629.
Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314.
Ley, K. and T. F. Tedder. 1995. Leukocyte interactions with vascular endothelium new insights into selectin-mediated attachment and rolling. J. Immunol. 155: 525-528.
McEver, R. P., K. L. Moore, and R. D. Cummings. 1995. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J. Biol. Chem. 270: 11025-11028.
Kansas, G. S. 1996. Selectins and their ligands: Current concepts and controversies. Blood 88: 3259-3287.
Jung, T. M. and M. O. Dailey. 1990. Rapid modulation of homing receptors (gp90MEL-14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. J. Immunol. 144: 3130-3136.
Carson, C. W., L. D. Beall, G. G. Hunder, C. M. Johnson, and W. Newman. 1993. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J. Rheumatol. 20: 809-814.
Donnelly, S. C., C. Haslett, I. Dransfield, C. E. Robertson, D. C. Carter, J. A. Ross, I. S. Grant, and T. F. Tedder. 1994. Role of selectins in development of adult respiratory distress syndrome. Lancet 344: 215-219.
Abe, K., T. Arai, M. Mori, H. Kida, S. Goya, H. Matsuoka, T. Osaki, I. Tachibana, and S. Hayashi. 1999. Effects of in vivo soluble selectin gene introduction on LPS-induced leukocyte accumulation into murine lung. Inflammation 23: 523-534.
Shirai, T., A. Sato, and K. Chida. 1995. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern. Med. 34: 469-474.
Honda, Y., Y. Kuroki, E. Matsuura, H. Nagae, H. Takahashi, T. Akino, and S. Abe. 1995. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am. J. Respir. Crit. Care. Med. 152: 1860-1866.
Kuwano, K., H. Miyazaki, N. Hagimoto, M. Kawasaki, M. Fujita, R. Kunitake, Y. Kaneko, and N. Hara. 1999. The involvement of Fas–Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell. Mol. Biol. 20: 53-60.
Kuwano, K., N. Hagimoto, M. Kawasaki, T. Yatomi, N. Nakamura, S. Nagata, T. Suda, R. Kunitake, T. Maeyama, H. Miyazaki, and N. Hara. 1999. Essential roles of the Fas–Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104: 13-19.
Honda, Y., Y. Kuroki, N. Shijubo, T. Fujishima, H. Takahashi, K. Hosoda, T. Akino, and S. Abe. 1995. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. Respiration 62: 64-69.
DeRemee, R. A. 1968. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 204: 1193-1195.
Cowley, H. C., D. Heney, A. J. Gearing, I. Hemingway, and N. R. Webster. 1994. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit. Care. Med. 22: 651-657.
Kuroki, Y., S. Tsutahara, N. Shijubo, H. Takahashi, M. Shiratori, A. Hattori, Y. Honda, S. Abe, and T. Akino. 1993. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am. Rev. Respir. Dis. 147: 723-729.
Kuroki, Y., H. Takahashi, H. Chiba, and T. Akino. 1998. Surfactant proteins A and D: Disease markers. Biochim. Biophys. Acta. 1408: 334-345.
Kohno, N., Y. Awaya, T. Oyama, M. Yamakido, M. Akiyama, Y. Inoue, A. Yokoyama, H. Hamada, S. Fujioka, and K. Hiwada. 1993. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am. Rev. Respir. Dis. 148: 637-642.
Yokoyama, A., N. Kohno, H. Hamada, M. Sakatani, E. Ueda, K. Kondo, Y. Hirasawa, and K. Hiwada. 1998. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 158: 1680-1684.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayashi, S., Abe, K., Matsuoka, H. et al. Increased Level of Soluble E-Selectin in the Serum from Patients with Idiopathic Pulmonary Fibrosis. Inflammation 28, 1–5 (2004). https://doi.org/10.1023/B:IFLA.0000014705.11961.c7
Issue Date:
DOI: https://doi.org/10.1023/B:IFLA.0000014705.11961.c7